Skip to content
Pharma Observatory a Scientist.com platform

Condition (MeSH)

Infant Nutrition Disorders

ClinicalTrials.gov lists 68 trials for Infant Nutrition Disorders or a narrower condition beneath it. Baxter Healthcare Corporation has the most among industry and government lead sponsors, with 2.

MeSH D007228 Nutritional and Metabolic Diseases C18
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Phase 1 Phase 1 1 Phase 1/2 Phase 1/2 1 Phase 2/3 Phase 2/3 1 Phase 3 Phase 3 3 Phase 4 Phase 4 2 Not applicable Not applicable 40 Observational Observational 20 Phase 1 Phase 1 1 Phase 1/2 Phase 1/2 1 Phase 2/3 Phase 2/3 1 Phase 3 Phase 3 3 Phase 4 Phase 4 2 Not applicable Not applicable 40 Observational Observational 20

Trials per phase (log scale)

67 of the 68 trials are tagged with Infant Nutrition Disorders itself; the rest are tagged with a narrower condition beneath it.

Get the Infant Nutrition Disorders report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

When did Infant Nutrition Disorders trials start? (17)

Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Trials over time, by phase

  • Phase 1
  • Phase 1/2
  • Phase 2/3
  • Phase 3
  • Phase 4
  • Not applicable
  • Observational

Top of scale: 7

2008: 2 trials (Observational 1, Phase 3 1) 2010: 4 trials (Not applicable 3, Phase 2/3 1) 2011: 4 trials (Observational 1, Not applicable 1, Phase 4 1, Phase 3 1) 2012: 2 trials (Observational 1, Phase 1/2 1) 2013: 4 trials (Observational 2, Not applicable 2) 2014: 7 trials (Observational 3, Not applicable 4) 2015: 1 trials (Observational 1) 2016: 1 trials (Observational 1) 2018: 4 trials (Observational 1, Not applicable 3) 2019: 4 trials (Not applicable 3, Phase 4 1) 2020: 7 trials (Observational 2, Not applicable 5) 2021: 5 trials (Observational 2, Not applicable 2, Phase 3 1) 2022: 2 trials (Observational 1, Not applicable 1) 2023: 5 trials (Observational 1, Not applicable 4) 2024: 7 trials (Observational 1, Not applicable 6) 2025: 6 trials (Observational 1, Not applicable 4, Phase 1 1)

Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 3
2025 6
2024 7
2023 5
2022 2
2021 5
2020 7
2019 4
2018 4
2016 1

No forecast is made for this condition: it averages 4.6 trial starts a year over the five years to September, under the 5 a year the method needs.

Prediction, not a registry value: median of 33 months from start to primary completion across 9 trials still running at the 2026-10-09 snapshot; registered median of 17 months across 40 trials with a primary completion typed Actual. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

What phase are Infant Nutrition Disorders trials in? (7)

Shown in this order: phase order.

Show the trials by phase as a table
Trials by phase
Phase Trials
Phase 1 1
Phase 1/2 1
Phase 2/3 1
Phase 3 3
Phase 4 2
Not applicable 40
Observational 20

How many Infant Nutrition Disorders trials are recruiting? (7)

Shown in this order: the order a trial moves through, from not yet recruiting to unknown.

Trials by recruitment status
Status Trials
Not yet recruiting 2
Recruiting 11
Active, not recruiting 7
Completed 32
Terminated 3

Status as registered on ClinicalTrials.gov. Each trial is counted once.

Which lead sponsors run the most Infant Nutrition Disorders trials? (3)

Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Lead sponsors
Sponsor Trials
Baxter Healthcare Corporation 2
Ausnutria Hyproca B.V. 1
Centre for Food and Nutrition Research, Yaounde 1

Which drugs are being tested for Infant Nutrition Disorders? (3)

Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.

Drugs tested
Drug Trials
Glucagon like peptide-2 1
Calcium-vitamin D3 1
Docosahexaenoic Acid 1

Interventions as named in the registry (6)

Shown in this order: most trials first.

Interventions as named in the registry
Drug Trials
IFA Incomplete Freund's Adjuvant 1
Standard Care 1
Not applicable- observational study 1
Ped3CB 1
Stool samples 1

These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.

Which publications cover Infant Nutrition Disorders? (109)

Shown in this order: major-topic papers first, then newest, then most linked to trials.

Sub-conditions in MeSH (1)

MeSH descendants one level down with at least one trial, most trials first.

Not on this page

Not measured: delivery record.

Checked, with nothing recorded for this condition: serious adverse events in this condition's trials, prevalence, and rare-disease identity.

Browse all condition evidence pages